北京市区域临床资源创新转化现状与对策

Effect analysis on technical innovation of clinical medicine resources in Beijing

目的评估北京市临床医学资源的转化现状与外溢效应,为促进盘活医院临床资源,促进成果创新转化提出建议。方法通过分析北京市临床医疗机构的专利、临床试验与成果转化案例,并进行国内外对比分析,发现制约临床资源成果外溢的因素,分析医疗机构在卫生健康体系中的作用。结果与国外先进水平相比,北京地区在临床资源的产出与产业支持方面还存在着很大发展空间。专利方面已经达到一定规模,但专利数量和增长率却低于上海。同等级医院专利数量相差较大,显示不同医院对于技术创新的重视程度与成果转化管理差异较大,缺乏区域层面统一的政策。北京是我国临床药物试验研究资源最为集中的代表性区域,其开展的临床试验数量超越上海和东京达到先进水平,在亚洲居于前列,但与国际先进区域有很大差距。结论医疗机构在卫生健康创新系统中,对于不同合作伙伴、不同阶段的重要作用和实现路径不同。建议加强临床创新政策保障与人才建设,促进以专利为核心的医疗成果外溢,建立临床资源技术创新良性循环。

Objective Evaluate the status quo and spillover effects of clinical medical resources in Beijing, to find solutions for promoting clinical resources of the hospital and transformation of clinical research. Methods By analyzing the patents, clinical trials and clinical research transformation cases of hospitals in Beijing, and comparing with advanced area at home and abroad, identify the factors that restrict the spillover of clinical resources, analyzed the role of medical institutions in the health system. Results Compare with the advanced level of abroad, there is a lot of space for improvement in Clinical resource output and industry support in Beijing. Beijing’s hospital patent amounts has reached a certain scale, however, the number and growth rate of patents is lower than Shanghai. The patents in different hospitals varies greatly, which indicating that the hospital′s emphasis on technological innovation and the overall transformation of results management are varied a lot, and overall, Beijing is lack of a unified policy at the regional level. Beijing is the most concentrated area of clinical medicine resources in China. The number of clinical trials carried out surpasses Shanghai and Tokyo in the forefront in Asia, but there is still a large gap to the international advanced region. Conclusions Hospitals is important in the health innovation system, It is recommended to strengthen the clinical innovation policy guarantee and talent construction, promote the patent-based medical results spillover, and establish a virtuous cycle of clinical resource technology innovation .